Skip to main content

Advertisement

SpringerLink
Log in

Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis

  • Short Report
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

The spectrum of Clostridium difficile-associated diarrhea (CDAD) is changing. Apart from antibiotic use, other risk factors such as use of proton pump inhibitors (PPI) and immunosuppressive agents, intensive care unit (ICU) stay and inflammatory bowel disease are being recognized. We retrospectively analyzed data on patients whose stool samples were tested for C. difficile toxin (CDT) by enzyme linked immunosorbent assay between June 2006 and May 2008. Demographic and clinical data, and risk factors (antibiotic use, underlying malignancy, chemotherapy, use of PPI, ICU stay) were noted. The details of treatment for CDAD, response, complication and follow up were recorded. Patients whose stool samples were CDT-positive were grouped as study subjects and those with negative stool samples were included in the control group. Of the 99 patients (mean age 46.7 years; 58 men) whose stool samples were tested during this period, 17 (17%) were positive for CDT. As compared with control subjects (n = 82), study subjects were more likely to have fever, prolonged ICU stay, underlying malignancy, and exposure to immunosuppressive and chemotherapeutic agents. On multivariate analysis, exposure to immunosuppressive agents was the only risk factor associated with CDAD. Fifteen patients were treated with metronidazole and two with vancomycin. Two patients did not respond to metronidazole but responded to vancomycin. No patient developed any complication. The prevalence of C. difficile toxin in diarrheal stools sent for C. difficile toxin testing was 17%. Exposure to immunosuppressive agents was a risk factor for the infection. Metronidazole was effective in a majority of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. McFarland LV. Diarrhea acquired in the hospital. Gastroenterol Clin North Am. 1993;22:563–77.

    PubMed  CAS  Google Scholar 

  2. Bartlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology. 1978;75:778–82.

    PubMed  CAS  Google Scholar 

  3. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002;34:346–53.

    Article  PubMed  Google Scholar 

  4. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med. 2002;346:334–9.

    Article  PubMed  Google Scholar 

  5. Morinville V, McDonald J. Clostridium difficile-associated diarrhea in 200 Canadian children. Can J Gastroenterol. 2005;19:497–501.

    PubMed  Google Scholar 

  6. Bauer MP, Goorhuis A, Koster T, et al. Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage – two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea. Neth J Med. 2008;66:207–11.

    PubMed  CAS  Google Scholar 

  7. Chakrabarti S, Lees A, Jones SG, Milligan DW. Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone Marrow Transplant. 2000;26:871–6.

    Article  PubMed  CAS  Google Scholar 

  8. Bilgrami S, Feingold JM, Dorsky D, et al. Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999;23:1039–42.

    Article  PubMed  CAS  Google Scholar 

  9. Keven K, Basu A, Re L, et al. Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation. Transpl Infect Dis. 2004;6:10–4.

    Article  PubMed  CAS  Google Scholar 

  10. Gorschluter M, Glasmacher A, Hahn C, et al. Clostridium difficile infection in patients with neutropenia. Clin Infect Dis. 2001;33:786–91.

    Article  PubMed  CAS  Google Scholar 

  11. Pulvirenti JJ, Mehra T, Hafiz I, et al. Epidemiology and outcome of Clostridium difficile infection and diarrhea in HIV infected in-patients. Diagn Microbiol Infect Dis. 2002;44:325–30.

    Article  PubMed  Google Scholar 

  12. Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol. 2007;102:2047–56. quiz 2057.

    Article  PubMed  Google Scholar 

  13. Rodemann JF, Dubberke ER, Reske KA, da Seo H, Stone CD. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339–44.

    Article  PubMed  Google Scholar 

  14. Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:345–51.

    Article  PubMed  Google Scholar 

  15. Kochhar R, Ayyagari A, Goenka MK, Dhali GK, Aggarwal R, Mehta SK. Role of infectious agents in exacerbations of ulcerative colitis in India. A study of Clostridium difficile. J Clin Gastroenterol. 1993;16:26–30.

    Article  PubMed  CAS  Google Scholar 

  16. Balamurugan R, Balaji V, Ramakrishna BS. Estimation of faecal carriage of Clostridium difficile in patients with ulcerative colitis using real time polymerase chain reaction. Indian J Med Res. 2008;127:472–7.

    PubMed  CAS  Google Scholar 

  17. Niyogi SK, Bhattacharya SK, Dutta P, et al. Prevalence of Clostridium difficile in hospitalised patients with acute diarrhoea in Calcutta. J Diarrhoeal Dis Res. 1991;9:16–9.

    PubMed  CAS  Google Scholar 

  18. Dhawan B, Chaudhry R, Sharma N. Incidence of Clostridium difficile infection: a prospective study in an Indian hospital. J Hosp Infect. 1999;43:275–80.

    Article  PubMed  CAS  Google Scholar 

  19. Chaudhry R, Joshy L, Kumar L, Dhawan B. Changing pattern of Clostridium difficile associated diarrhoea in a tertiary care hospital: a 5 year retrospective study. Indian J Med Res. 2008;127:377–82.

    PubMed  Google Scholar 

  20. Katyal R, Vaishnavi C, Singh K. Faecal excretion of brush border membrane enzymes in patients with clostridium difficile diarrhoea. Indian J Med Microbiol. 2002;20:178–82.

    PubMed  CAS  Google Scholar 

  21. Gupta U, Yadav RN. Clostridium difficile in hospital patients. Indian J Med Res. 1985;82:398–401.

    PubMed  CAS  Google Scholar 

  22. Ayyagari A, Sharma P, Venkateswarlu, Mehta S, Agarwal KC. Prevalence of Clostridium difficile in pseudomembranous and antibiotic-associated colitis in north India. J Diarrhoeal Dis Res. 1986;4:157–60.

    PubMed  CAS  Google Scholar 

  23. Al-Eidan FA, McElnay JC, Scott MG, Kearney MP. Clostridium difficile-associated diarrhoea in hospitalised patients. J Clin Pharm Ther. 2000;25:101–9.

    Article  PubMed  CAS  Google Scholar 

  24. Niyogi SK. Clostridium difficile – associated diarrhoeal diseases: an overview. J Indian Med Assoc. 1995;93:105–7.

    PubMed  CAS  Google Scholar 

  25. Vaishnavi C, Thapa BR, Thennarasu K, Singh K. Faecal lactoferrin assay as an adjunct to Clostridium difficile diarrhoea. Indian J Pathol Microbiol. 2002;45:69–73.

    PubMed  Google Scholar 

  26. Gogate A, De A, Nanivadekar R, et al. Diagnostic role of stool culture and toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children. Indian J Med Res. 2005;122:518–24.

    PubMed  CAS  Google Scholar 

  27. Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile-associated diarrhea: a review. Arch Intern Med. 2001;161:525–33.

    Article  PubMed  CAS  Google Scholar 

  28. Kelly CP, LaMont JT. Clostridium difficile infection. Annu Rev Med. 1998;49:375–90.

    Article  PubMed  CAS  Google Scholar 

  29. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40:1–15.

    Article  PubMed  CAS  Google Scholar 

  30. Vaishnavi C, Bhasin D, Kochhar R, Singh K. Clostridium difficile toxin and faecal lactoferrin assays in adult patients. Microbes Infect. 2000;2:1827–30.

    Article  PubMed  CAS  Google Scholar 

  31. Karlstrom O, Fryklund B, Tullus K, Burman LG. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis. 1998;26:141–5.

    Article  PubMed  CAS  Google Scholar 

  32. Dial S, Delaney JA, Schneider V, Suissa S. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ. 2006;175:745–8.

    PubMed  Google Scholar 

  33. Kumar B, Vaishnavi C, Sandhu K, Kaur I. Clostridium difficile toxin assay in psoriatic patients. Trop Gastroenterol. 2004;25:164–7.

    PubMed  Google Scholar 

  34. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45:302–7.

    Article  PubMed  CAS  Google Scholar 

  35. Pepin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171:466–72.

    PubMed  Google Scholar 

  36. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–55.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, P D Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai, 400 016, India

    Meghraj Ingle, Abhijit Deshmukh, Devendra Desai, Philip Abraham & Anand Joshi

  2. Division of Microbiology, P D Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai, 400 016, India

    Camilla Rodrigues

  3. Division of Research, P D Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mumbai, 400 016, India

    Ranjit Mankeshwar

Authors
  1. Meghraj Ingle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abhijit Deshmukh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Devendra Desai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Philip Abraham
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anand Joshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Camilla Rodrigues
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ranjit Mankeshwar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Devendra Desai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ingle, M., Deshmukh, A., Desai, D. et al. Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis. Indian J Gastroenterol 30, 89–93 (2011). https://doi.org/10.1007/s12664-011-0097-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-011-0097-5

Keywords

Search

Navigation